Qiagen Germany News and Activities

Qiagen Germany is owned by Qiagen.

Qiagen is one of the...

• Dax 40;
• Russell 3000;
• Stoxx 600;
• TOB Iconic 10,000.

Qiagen is a company listed under the stock ticker Qiagen NV (DE).

View the org chart displaying its 6 main executives

Most searched biographies at Qiagen Germany

• Thomas Deutschmann, Director, System Integration
• Carola Schade, Vice President, Global Head of Marketing
• Peter Bierbaum, Director Global Pricing and Business Analytics

Popular executive movements at Qiagen

• Salvatore Mazza, Business Development Manager, has left the company  (posted on May 5 2026).
• Mark Stevenson has joined the company as Independent Director  (posted on January 27 2026).
• Ross Levine, Director, has left the company  (posted on January 27 2026).

Click here to view some more movements at Qiagen

Create your alert
to follow the executive moves at Qiagen Germany.

Qiagen has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Qiagen Germany

Social media about Qiagen Germany

• Qiagen Germany on Wikipedia, Google News & Yahoo Finance
• Qiagen Germany on LinkedIn, X (Twitter) & YouTube